The correlation between abnormal levels of cholesterol and different types of cancer has been widely explored; more specifically, the expression of sterol regulatory element-binding protein 2 (SREBP2) has been correlated with the evolution of hepatocellular carcinoma. The gene discussed is SREBF2; the disease is cancer.